Sun Pharma Halol facility gets OAI from USFDA
New Delhi: Sun Pharmaceutical Industries Limited has announced that the Company has received a communication from the USFDA indicating the inspection classification of Halol at Gujarat facility as "Official Action Indicated" (OAI).The OAI classification implies inter-alia that the USFDA may withhold approval of any pending product applications or supplements filed from this facility till...
New Delhi: Sun Pharmaceutical Industries Limited has announced that the Company has received a communication from the USFDA indicating the inspection classification of Halol at Gujarat facility as "Official Action Indicated" (OAI).
Read also: Sun Pharma gets 6 USFDA observations for Mohali facility
Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. The company manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates.
Read also: Sun Pharma, Dr Reddy's Labs and 2 others recall products in US
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd